CRISPR/Cas-induced double-strand breaks boost the frequency of gene replacements for humanizing the mouse Cnr2 gene.
暂无分享,去创建一个
[1] C. Barbas,et al. ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. , 2013, Trends in biotechnology.
[2] George M. Church,et al. Multiplex and homologous recombination–mediated genome editing in Arabidopsis and Nicotiana benthamiana using guide RNA and Cas9 , 2013, Nature Biotechnology.
[3] Jan Freudenberg,et al. Cannabinoid receptor type 2 gene is associated with human osteoporosis. , 2005, Human molecular genetics.
[4] A. Zimmer. Manipulating the genome by homologous recombination in embryonic stem cells. , 1992, Annual review of neuroscience.
[5] M. Itokawa,et al. Brain Cannabinoid CB2 Receptor in Schizophrenia , 2010, Biological Psychiatry.
[6] Bob Goldstein,et al. Engineering the Caenorhabditis elegans Genome Using Cas9-Triggered Homologous Recombination , 2013, Nature Methods.
[7] M. de Bono,et al. Efficient genome editing in Caenorhabditis elegans by CRISPR-targeted homologous recombination , 2013, Nucleic acids research.
[8] Li Wang,et al. Erratum: Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting (Nucleic Acids Research (2011) 39 (e82) DOI: 10.1093/nar/gkr218) , 2011 .
[9] H. Bluethmann,et al. Targeted disruption of the MHC class II Aa gene in C57BL/6 mice. , 1993, International immunology.
[10] R. Jaenisch,et al. Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases , 2009, Nature Biotechnology.
[11] Erin L. Doyle,et al. Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting , 2011, Nucleic acids research.
[12] Emmanuelle Charpentier,et al. The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems , 2013, RNA biology.
[13] Susan Carpenter,et al. Modularly assembled designer TAL effector nucleases for targeted gene knockout and gene replacement in eukaryotes , 2011, Nucleic acids research.
[14] Samira Kiani,et al. Genetic engineering of human ES and iPS cells using TALE nucleases , 2011, Nature Biotechnology.
[15] F. Max. The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems , 2013 .
[16] Le Cong,et al. Multiplex Genome Engineering Using CRISPR/Cas Systems , 2013, Science.
[17] C. Stewart,et al. Derivation of embryonic stem cell lines. , 1993, Methods in enzymology.
[18] H. Green,et al. QUANTITATIVE STUDIES OF THE GROWTH OF MOUSE EMBRYO CELLS IN CULTURE AND THEIR DEVELOPMENT INTO ESTABLISHED LINES , 1963, The Journal of cell biology.
[19] Yongxiang Zhao,et al. Heritable gene targeting in the mouse and rat using a CRISPR-Cas system , 2013, Nature Biotechnology.
[20] P. Nürnberg,et al. The cannabinoid receptor type 2 (CNR2) gene is associated with hand bone strength phenotypes in an ethnically homogeneous family sample , 2009, Human Genetics.
[21] C. Wolf,et al. Generation and utility of genetically humanized mouse models. , 2013, Drug discovery today.
[22] F. Locatelli,et al. Cannabinoid Receptor Type 2 Functional Variant Influences Liver Damage in Children with Non-Alcoholic Fatty Liver Disease , 2012, PloS one.
[23] Rudolf Jaenisch,et al. One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome Engineering , 2013, Cell.
[24] T. Bonner,et al. Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor. , 2000, European journal of pharmacology.
[25] D. Menke. Engineering subtle targeted mutations into the mouse genome , 2013, Genesis.